Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Immucell Corp /De/ quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
Immucell Corp /De/ Operating Income (Loss) for the quarter ending September 30, 2024 was -$575K, a 51.4% increase year-over-year.
Immucell Corp /De/ Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.27M, a 48.8% increase year-over-year.
Immucell Corp /De/ annual Operating Income (Loss) for 2023 was -$5.75M, a 150% decline from 2022.
Immucell Corp /De/ annual Operating Income (Loss) for 2022 was -$2.3M, a 993% decline from 2021.
Immucell Corp /De/ annual Operating Income (Loss) for 2021 was $257K.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	-$5.75M	-$3.45M	-150%	Jan 1, 2023	Dec 31, 2023	10-Q	2024-11-13
2022	-$2.3M	-$2.56M	-993%	Jan 1, 2022	Dec 31, 2022	10-Q	2024-11-13
2021	$257K	+$1.64M		Jan 1, 2021	Dec 31, 2021	10-Q	2023-11-13
2020	-$1.38M	-$426K	-44.7%	Jan 1, 2020	Dec 31, 2020	10-Q	2022-11-21
2019	-$954K	+$493K	+34.1%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-30
2018	-$1.45M	-$1.2M	-496%	Jan 1, 2018	Dec 31, 2018	10-K	2020-03-27
2017	-$243K	-$1.13M	-127%	Jan 1, 2017	Dec 31, 2017	10-K	2019-03-22
2016	$890K	-$1.23M	-58.1%	Jan 1, 2016	Dec 31, 2016	10-K	2018-03-29
2015	$2.12M	+$2.33M		Jan 1, 2015	Dec 31, 2015	10-K	2017-03-30
2014	-$206K	-$187K	-956%	Jan 1, 2014	Dec 31, 2014	10-K	2016-03-25
2013	-$19.6K	-$265K	-108%	Jan 1, 2013	Dec 31, 2013	10-K	2016-03-25
2012	$245K	+$878K		Jan 1, 2012	Dec 31, 2012	10-K	2015-03-26
2011	-$633K	+$57.6K	+8.34%	Jan 1, 2011	Dec 31, 2011	10-K	2014-03-26
2010	-$690K			Jan 1, 2010	Dec 31, 2010	10-K	2013-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.